Menlo Park, CA, United States of America

Neda Mahmoudi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Recode Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neda Mahmoudi. Retrieved from https://idiyas.com/inventor/neda-mahmoudi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neda Mahmoudi: Innovator in Lipid Nanoparticle Compositions

Introduction

Neda Mahmoudi is a prominent inventor based in Menlo Park, California. She has made significant contributions to the field of pharmaceutical compositions, particularly through her innovative work with lipid nanoparticles.

Latest Patents

Neda holds a patent for "Lipid nanoparticle compositions and uses thereof." This patent includes aerosolized pharmaceutical compositions that comprise aerosol particles, specifically lipid nanoparticles (LNPs). The patent also outlines methods for administering these aerosolized pharmaceutical compositions, showcasing her expertise in this cutting-edge area of research.

Career Highlights

Neda is currently employed at Recode Therapeutics, Inc., where she continues to advance her research and development efforts. Her work is pivotal in the exploration of new therapeutic methods that utilize lipid nanoparticles.

Collaborations

Neda collaborates with talented individuals in her field, including Sahitya Katikaneni and Peng Wang. These partnerships enhance her research and contribute to the innovative environment at Recode Therapeutics.

Conclusion

Neda Mahmoudi is a trailblazer in the development of lipid nanoparticle technologies, with her patent reflecting her commitment to advancing pharmaceutical science. Her contributions are shaping the future of drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…